TANGO-TNG462C102 A phase 1, 2 open label study to evaluate the safety and tolerability and preliminary anti-tumor activity of TNG 462 in patients with MTAP deleted advanced/metastatic solid tumors

  • Phase I
  • Trial Category: Other Solid Tumor

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Nebraska Cancer Specialists, Omaha and Grand Island, NE locations

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*